Exelixis, Inc. (EXEL)
NASDAQ·Healthcare·Biotechnology
$56.10
+1.83%
Mkt Cap $13.84B
Analyst Ratings
Buy
4
Hold
12
Sell
0
Price Target (57 analysts)
$50.00
Range $44.00 – $56.00
Implied Upside
-10.9%
Consensus $50.00 vs current $56.10
NASDAQ·Healthcare·Biotechnology
$56.10
+1.83%
Mkt Cap $13.84B
Buy
4
Hold
12
Sell
0
Price Target (57 analysts)
$50.00
Range $44.00 – $56.00
-10.9%
Consensus $50.00 vs current $56.10